Related Experiment Video
Updated: Jun 13, 2026
08:46
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Aspirin and clopidogrel resistance: methodological challenges and opportunities
1Clinical Research Unit, Russell's Hall Hospital, Dudley Group of Hospitals NHS Foundation Trust, West Midlands, UK. a.gasparyan@gmail.com
Vascular Health and Risk Management
|May 8, 2010
Summary
Drug resistance to aspirin and clopidogrel is a significant cardiovascular issue. Current platelet function tests lack standardization, hindering accurate resistance assessment and reliable monitoring of antiplatelet therapy effectiveness.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Hematology
Background:
- Antiplatelet drug resistance poses a critical challenge in managing cardiovascular diseases.
- Aspirin and clopidogrel are commonly prescribed antiplatelet agents.
- Patient responsiveness to these drugs varies, necessitating reliable monitoring methods.
Purpose of the Study:
- To critically evaluate current methods for assessing aspirin and clopidogrel resistance.
- To highlight limitations in existing platelet function tests used in cardiovascular interventions.
- To explore alternative approaches for monitoring antiplatelet therapy.
Main Methods:
- Review of existing literature on antiplatelet drug resistance.
- Analysis of commonly used platelet function tests and their methodologies.
- Discussion of arbitrary cut-off values in resistance studies.
- Consideration of platelet size measurement as a potential monitoring tool.
Main Results:
- Significant variability exists in reported prevalence of aspirin and clopidogrel resistance due to differing test methodologies.
- Current platelet function tests demonstrate poor correlation, leading to inconsistent patient classification.
- Arbitrary selection of cut-off values complicates the interpretation of resistance.
- Platelet size measurement emerges as a potentially promising, yet underutilized, method.
Conclusions:
- Existing platelet function tests have limitations for accurately defining aspirin and clopidogrel resistance.
- The lack of standardized testing and arbitrary cut-offs impede reliable patient assessment.
- Further research into standardized platelet function tests, including platelet size, is warranted for effective antiplatelet therapy monitoring in patients undergoing coronary interventions.
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...